PCF 2020 - 27th Annual Prostate Cancer Foundation Scientific Retreat (Virtual Meeting)
Oct 20 - Oct 23, 2020 | CarlsbadCAUS
LARVOL is not affiliated with 27th Annual Prostate Cancer Foundation Scientific Retreat (Virtual Meeting) and all trademarks, logos, and brand names are property of their respective owners
Showing 5 abstracts linked to Trials
[VIRTUAL] A Phase 2 Study of the Polo-like kinase 1 (PLK1) inhibitor, Onvansertib, in Combination with Abiraterone in Patients with Abiraterone (Abi)-Resistant Metastatic Castration-Resistant Prostate Cancer (mCRPC)
[VIRTUAL] Preoperative Trial of Neo Adjuvant Abiraterone Plus Or MInus Cabazitaxel: Early Results
[VIRTUAL] EPI-7386, a potent N-terminal domain androgen receptor inhibitor, with a favorable preclinical safety and superior in vitro/in vivo profile, in clinical development for prostate cancer
[VIRTUAL] Identification of Novel Therapies for RB-deficient Castration-Resistant Prostate Cancer
[VIRTUAL] Novel Immunotherapy Combinations Against Castration-Resistant Prostate Cancer